Jul 24, 2023 / 12:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Alnylam Pharmaceuticals conference call to discuss Roche partnership. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to the company. Please go ahead.
Christine Regan Lindenboom - Alnylam Pharmaceuticals, Inc. - Senior VP of IR & Corporate Communications
Good morning. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today on the phone are Yvonne Greenstreet, Chief Executive Officer; Pushkal Garg, Chief Medical Officer; Evan Lippman, Chief Corporate Development and Strategy Officer; and Jeff Poulton, Chief Financial Officer; Tolga Tanguler, our Chief Commercial Officer, is also in the room and available for Q&A. For those of you participating via conference call, the accompanying slides can be accessed by going to the Events section of the Investors page of our website investors.alnylam.com/events.
During today's call, as outlined
Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot